Okumura; Ko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Okumura; Ko.The latest application filed is for "antibody inducing immune tolerance, induced lymphocyte, and cell therapy agent therapeutic method using induced lymphocyte".

Company Profile

3.7.6

Okumura; Ko - Tokyo JP
Okumura; Ko - Chiba City JP
Okumura; Ko - Tokyo-to JP
Okumura; Ko - Chiba JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody Inducing Immune Tolerance, Induced Lymphocyte, And Cell Therapy Agent Therapeutic Method Using Induced Lymphocyte App 20210269529 - Maeda; Ryu ; et al.	2021-09-02
Antibody Capable Of Inducing Immune Tolerance Produced Using Cell Mixture Having Complexed State, And Induced Lymphocyte Or Cell Therapeutic Agent And Cell Therapy Method Each Using Induced Lymphocyte App 20210260124 - Uchida; Koichiro ; et al.	2021-08-26
Composition For Eliciting Infectious Immunological Tolerance App 20210261664 - Uchida; Koichiro ; et al.	2021-08-26
T Regulatory Cells And Uses Thereof App 20200079853 - Todo; Satoru ; et al.	2020-03-12
Combined-blade open flow path device and joined body thereof Grant 10,258,982 - Hariyama , et al.	2019-04-16
Antibody titer-increasing agent using lactic acid bacterium Grant 10,195,271 - Makino , et al. Fe	2019-02-05
Combined-blade-type Open Flow Path Device And Joined Body Thereof App 20170044002 - HARIYAMA; Takahiko ; et al.	2017-02-16
T Regulatory Cells And Uses Thereof App 20160046715 - Todo; Satoru ; et al.	2016-02-18
Monoclonal antibody reacting specifically reacting with Fas ligand and production process thereof Grant 6,946,255 - Kayagaki , et al. September 20, 2	2005-09-20
Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligand Grant 6,777,540 - Okumura , et al. August 17, 2	2004-08-17
Antiallergic compostion Grant 6,090,384 - Ra , et al. July 18, 2	2000-07-18
Drug for the treatment of rheumatoid arthritis Grant 5,855,888 - Nishida , et al. January 5, 1	1999-01-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.